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MitoBlue as a tool to analyze 
the mitochondria-lysosome 
communication
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M. eugenio Vázquez  1, Ayumu Sugiura  2,3,7* & José Martínez-costas  5*
MitoBlue is a fluorescent bisamidine that can be used to easily monitor the changes in mitochondrial 
degradation processes in different cells and cellular conditions. MitoBlue staining pattern is exceptional 
among mitochondrial dyes and recombinant fluorescent probes, allowing the dynamic study of 
mitochondrial recycling in a variety of situations in living cells. MitoBlue is a unique tool for the study of 
these processes that will allow the detailed characterization of communication between mitochondria 
and lysosomes.
Cells maintain a functional mitochondrial network and avoid the buildup of defective mitochondria through 
a complex equilibrium between organelle fission and fusion, which isolates damaged organelles and redistrib-
utes their contents for recycling1–3. Mitochondrial quality control is maintained through multiple pathways, 
including intramitochondrial proteases, proteasomal degradation, mitochondrial-derived vesicles (MDVs), and 
mitophagy—the specific autophagic degradation of mitochondria4–6. Additionally, functional mitochondria are 
dependent on a number of dynamic processes, including fusion, fission, mobility, and direct contact with other 
organelles. Thus, mitochondrial quality control and dynamics are tightly coupled, and the disruption of this 
equilibrium leads to abnormal dynamics4. Disorders in mitochondrial homeostasis is at the origin of many phys-
iopathological conditions and diseases7, including cancer or neurodegenerative diseases, such as Alzheimer’s 
and Parkinson’s disease8,9. Furthermore, mitochondrial quality control seems to have a close link with aging10–12. 
Thus, given its central role in such a wide array of fundamental processes13, the development of probes to study 
mitochondria dynamic processes represents an important challenge with great potential in basic and applied 
biomedical research14–16.
Mitochondrial quality can be evaluated by imaging analysis with fluorescent microscopy, using antibodies, 
reporter proteins or chemical probes, and by electron microscopy (EM) to characterize mitochondrial ultras-
tructures17–19. However, most of these techniques require cellular fixation, which can affect cellular structures 
and prevent the observation of dynamic processes, such as the formation of vesicles involved in some of the 
alternative degradation mechanisms affecting mitochondria. Recent imaging techniques allow the visualization of 
mitochondria associated molecular events with extraordinary sensitivity, and with selectivity and spatio-temporal 
resolution20–22. For example, using the reporter mRFP-GFP-LC3 it is possible to label different stages in auto-
phagy by monitoring the evolution of the fluorescence emission profile resulting from the acidification of the 
autophagosome23,24. However, despite their widespread use, biosensors based on large protein constructs suffer 
from significant limitations, such as the need for transfection and over-expression, relatively low photostability, 
and large size that can lead to interference at the molecular level, poor biodistribution and pharmacokinetics, 
or immune response25. Small-molecule fluorophores offer several advantages over genetically encoded probes, 
such as highly efficient and homogeneous staining and bright emission. Furthermore, given that they do not 
need to be expressed, they can be used in cell cultures by simple incubation protocols26. In addition to classic 
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Figure 1. Mitochondrial localization of MitoBlue (1). (A) MitoBlue is a membrane potential-independent dye. 
HeLa cells were incubated with 5 µM MitoBlue, 200 nM tetramethylrhodamine ethyl ester (TMRE), and 50 nM 
Mitotracker Deep Red (MTDR) after five min preincubation with either DMSO (top panels) or 100 µM CCCP 
(bottom panels). Scale bars: 20 μm. (B) No binding to mtDNA in cellulo. HeLa cells were incubated with 5 µM 
MitoBlue and 100 nM Mitotracker Deep Red (MTDR) in standard conditions, washed, and further incubated 
in culture medium for 15 min at 37 °C. The cells were fixed and subjected to immunofluorescence staining using 
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Mitotracker stains that localize in the mitochondria27,28, a number of alternative mitochondrial dyes have been 
recently described29–34. Indeed, to the best of our knowledge, there is only one example in the literature of an 
organic probe that can be used to monitor mitophagy. This compound consists of a cyanine dye that stains mito-
chondria (emitting at 650 nm), and that upon mitophagic degradation is transported into the acidic lysosomes, 
where in its protonated form emits at a longer wavelength (750 nm)35.
We have recently reported the synthesis and biophysical characterization of MitoBlue (1, Fig. 1), a 
blue-emitting fluorescent dye that stains functional mitochondria, displaying low toxicity and high resistance to 
photobleaching, even after fixation of cells with paraformaldehyde36. Herein we demonstrate that, in addition to 
being an efficient mitochondrial stain, MitoBlue is relocalized to lysosomes in a time-dependent manner, likely 
through a membrane dynamic process, and that this migration may be used as an indicator of mitochondrial 
recycling activity in cells subjected to different environments stimuli, or states, such as aging. Therefore, MitoBlue 
is much more than a simple Mitotracker, but can be used to dynamically monitor the mitochondrial quality by 
tracking its migration to lysosomes. We also demonstrate that MitoBlue is a suitable dye for two-photon micros-
copy, which allows irradiation at longer wavelengths than those required in standard fluorescence spectroscopy 
at 329 nm.
Results
Mitochondrial localization of MitoBlue. The initial mitochondrial localization of MitoBlue is consist-
ent with the observed distribution of other delocalized lipophilic cations37, such as Rhodamine 12338, tetraphe-
nylphosphonium39, and even related bisbenzamidines40, which suggests that MitoBlue could be electrostatically 
driven to the mitochondria by the large electrochemical potential generated by the electron transport chain41. 
Interestingly, unlike Rhodamine 123, MitoBlue is retained in mitochondria after fixation. Preliminary exper-
iments using long incubation times had suggested that MitoBlue did not label mitochondria of CCCP-treated 
cells38. The mitochondrial uncoupler CCCP is a protonophore that mediates the diffusion of protons across the 
inner mitochondrial membrane, thus causing the loss of the membrane potential. However, repeating these 
experiments at shorter times and using positive controls, indicate that the mitochondria staining is relatively 
independent of the membrane potential. Therefore, we treated HeLa cells during 5 min with Carbonyl Cyanide 
3-ChloroPhenylhydrazone (CCCP), prior to their staining with either MitoBlue, and tetramethylrhodamine 
ethyl ester (TMRE), or Mitotracker Deep Red (MTDR) as controls. As shown in Fig. 1A (left column), MitoBlue 
targeted mitochondria equally efficiently in the presence of CCCP, while mitochondrial staining with TMRE 
(Fig. 1A, middle column) and MTDR (Fig. 1A, right column) fainted upon incubation with the uncoupler. 
This experiment was repeated using FCCP as the uncoupling agent with the same results, thus confirming that 
MitoBlue targets mitochondria in a membrane potential-independent manner.
MitoBlue, like propamidine or 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI), belongs to the bis-
benzadimine family of DNA-binding agents, and indeed, we have previously demonstrated that MitoBlue displays 
significant affinity for A/T-rich DNA sequences in vitro36. Therefore, we wondered whether MitoBlue might target 
mitochondrial DNA (mtDNA). To answer that question, HeLa cells were stained with MitoBlue and Mitotracker 
Deep Red (MTDR), fixed with PFA, and subjected to immunofluorescence staining using with antibodies against 
mtDNA. Analysis of this preparation by confocal microscopy showed the expected punctuated pattern of mtDNA 
concentrated in nucleolids (Fig. 1B, mtDNA)42; in contrast, MitoBlue was diffusely distributed in mitochondria 
and matching the staining pattern of MTDR, clearly indicating no mtDNA targeting. To obtain more insight into 
the exact mitochondrial localization of MitoBlue, COS-7 cells stained with MitoBlue were subjected to immuno-
fluorescence analysis by simultaneously using antibodies against Tom20, a mitochondrial membrane protein43, 
and the mitochondrial matrix resident protein Pyruvate Dehydrogenase E2/E3bp (PDH). The images in Fig. 1C 
showed a clear difference in the staining pattern of MitoBlue and Tom20, but a clear colocalization with PDH 
(Fig. 1C), suggesting that MitoBlue is dominantly targeting the mitochondrial matrix and/or inner membrane. In 
fact, line scan analysis further shows that the peaks of fluorescence intensity of MitoBlue and PDH are between 
the two peaks of Tom20 (Fig. 1D).
MitoBlue is transferred from mitochondria to lysosomes with time. We have previously shown that 
MitoBlue labels mitochondria with excellent selectivity, while causing no harm to cells36. To further evaluate its 
value as a mitochondrial stain, we wanted to assess for how long MitoBlue remains associated with mitochondria. 
To test this, Vero cells were incubated with 5 μM MitoBlue for 20–30 min at 37 °C, replenished with fresh medium, 
and then incubated at 37 °C for several hours. Observation under the microscope just after the washing step, at the 
beginning of the experiment, showed that MitoBlue was distributed in a filamentous pattern typical of mitochon-
dria (Fig. 2A, 0 h, middle panel) that also matched the localization of Mitotracker Red (Fig. 2A, 0 h, right panel). 
At 24 h post-labelling, we counter-stained the cells with Rhodamine 123, a membrane potential-dependent dye 
that exclusively stains functional mitochondria. While the signal of Rhodamine 123 revealed the typical mito-
chondria pattern (Fig. 2A, 24 h, right panel), the signal of MitoBlue was concentrated into punctuated vesicle-like 
structures with a completely different distribution from that of Rhodamine 123 (Fig. 2A, 24 h, middle panel). 
These results suggest that with time MitoBlue leaves mitochondria and ends up accumulating in vesicle-like struc-
tures, and that mitochondria of these cells are not damaged. This behaviour is not shared neither by Mitotracker 
anti-DNA antibody. Scale bar: 10 μm. (C) MitoBlue intra-mitochondrial localization. COS-7 cells labeled with 
5 μM MitoBlue were subjected to immunofluorescence staining using anti-Tom20 and -PDH antibodies. Scale 
bar: 5 μm. (D) Line scan co-localization analysis of MitoBlue, PDH, and Tom20, corresponding to the white line 
on the left image in (C).
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Red or Rhodamine 123, whose staining remains mitochondrial at similar incubation times (data not shown). 
This interesting distribution pattern led us to explore whether MitoBlue was transferred to lysosomes. As an 
initial approach, Vero cells were stained with MitoBlue as described before, and counter stained with Lysotracker 
30 min prior to observation at selected time points. In agreement with our previous observations, MitoBlue first 
stains mitochondria, showing an initial distribution completely different to that of Lysotracker (Fig. 2B, 0 h, upper 
row); at 3 h post-staining, some vesicles were simultaneously stained with MitoBlue and Lysotracker (Fig. 2B, 
3 h middle row), and at 7 h post-treatment, both reagents showed an increasing coincidence, suggesting the 
time-dependent transfer of MitoBlue from mitochondria to lysosomes (Fig. 2B, 7 h lower row).
To unequivocally identify the vesicles receiving the MitoBlue as lysosomes, HeLa cells were coincubated with 
MitoBlue and Mitotracker Deep Red (MTDR). After the fixation, cells were immunostained with antibodies 
against the lysosome-associated membrane glycoprotein 1 (Lamp1), a transmembrane protein which resides pri-
marily across lysosomal membranes, and observed by confocal microscopy44. As shown in Fig. 2C, MitoBlue 
overlaps with MTDR at early times post-staining (Fig. 2C, 0 min, Pearson’s coefficient between MitoBlue and 
MTFR 0.964 ± 0.003, MitoBlue and Lamp1b 0.650 ± 0.014, MTFR and Lam1b 0.640 ± 0.014). The coincidence 
between MitoBlue and Lamp1 is already detectable at 30 min and becomes evident at later times post-staining 
(Fig. 2C, arrows), reinforcing our previous observation that lysosomes are the destination of the MitoBlue stain. 
On the other hand, MTDR labelling does not overlap at all with Lamp1, indicating that MitoBlue was selectively 
transferred to lysosomes (Fig. 2C, 420 min, Pearson’s coefficient between MitoBlue and MTFR 0.847 ± 0.014, 
MitoBlue and Lamp1b 0.754 ± 0.018, MTFR and Lam1b 0.479 ± 0.014).
MitoBlue potentially traces several different mitochondria recycling processes. Which is the 
mechanism of translocation of MitoBlue from mitochondria to lysosomes? The formation of MDVs (mito-
chondria derived vesicles) is one of the mechanisms used by nature for mitochondrial quality control, and is 
based on the incorporation of damaged proteins—and probably also lipids—into vesicles, which are released 
from mitochondria45. MDVs can be distinguished from fragmented mitochondria and other vesicles inside the 
Figure 2. MitoBlue travels from mitochondria to lysosomes with time. (A) Co-staining untreated cells with 
Mitotracker. Vero cells were incubated with the indicated probes. Images were acquired just after simultaneous 
staining with Mitotracker Red and MitoBlue (0 h, top panels) or just after staining with Rhodamine 123 
24 h after MitoBlue addition (24 h, bottom panels). Scale bars: 10 μm. (B) Co-staining untreated cells with 
Lysotracker. Vero cells were incubated with 5 µM MitoBlue and 50 nM Lysotracker Red. Images were acquired at 
indicated times after staining. (C) MitoBlue travels from mitochondria to lysosomes with time. HeLa cells were 
incubated with 5 μM MitoBlue, 100 nM Mitotracker Deep Red (MTDR) and immunostained with anti-Lamp1b 
antibody at the times post-staining indicated on the left of the images. Arrowheads indicate co-localization 
between MitoBlue and Lamp1b, but not MTDR. Scale bars: 5 μm. Line graph indicates quantification of 
colocalization calculated as Pearson’s coefficient between indicated labels at each time point. Error bars the 
means ± S.E. 17 cells were quantified at each time point.
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Figure 3. MitoBlue is transferred from mitochondria to lysosome by membrane traffic. (A) MitoBlue is 
not incorporated into conventional MDVs. COS-7 cells incubated with 5 µM MitoBlue were subjected to 
immunofluorescence using anti-PDH and -Tom20 antibodies. Circles show MitoBlue+/PDH−/Tom20− vesicles. 
Scale bars: 5 μm. (B) Partial localization of MitoBlue with autophagic vesicles. A541 cells were transfected with 
ptfLC3 vector. 24 hours post-transfection, the cells were labelled with 5 µM MitoBlue for 30 minutes, washed 
and further incubated for 4 hours in complete medium supplemented with 1 µM Rapamycin. The fluorescence 
of GFP (green LC3), mRFP (red LC3) or MitoBlue was observed without fixation by confocal live-cell imaging. 
Arrowhead indicates vesicles simultaneously stained with MitoBlue and mRFP, open arrowhead indicates 
vesicles simultaneously stained with MitoBlue, GFP and mRFP and circle indicates multivesicular body 
containing MitoBlue. Scale bar: 5 μm. (C) Acidic lysosomes are required for MitoBlue transfer to lysosomes. 
MCH74 cells grown in galactose medium were treated incubated with 5 µM MitoBlue and 30 μM Antimycin 
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crowded cytosol by probing with at least two mitochondrial markers. Thus, HeLa cells, post-MitoBlue staining, 
were subjected to immunofluorescence analysis using anti-Tom20 and PDH antibodies, which are known car-
goes of MDVs. As shown in Fig. 3A, HeLa cells presented both Tom20+/PDH− and Tom20−/PDH+ vesicle-like 
structures (Fig. 3A). MitoBlue also showed vesicle-like structures which were negative for either Tom20 or PDH 
(Fig. 3A, circles). As MitoBlue initially target mitochondria, these results suggest that it might be released from 
them by non-conventional MDVs.
Elimination of MitoBlue through mitophagic recycling of mitochondrial components could be another addi-
tional explanation for the unexpected behavior of the stain. To test this hypothesis, A541 cells were transfected 
with mRFP-GFP-LC3, which has been shown to selectively mark autophagosomes24, and stained with MitoBlue 
24 h after transfection (Fig. 3B). The cells were then immediately observed under the confocal microscope, or 
further incubated for 4 h in the presence of 1 µM Rapamycin, which is known to induce both mitophagy and auto-
phagy. As expected, immediately after incubation, MitoBlue was concentrated in the mitochondrial network, and 
did not superimpose with the LC3-tagged autophagic marker (not shown), but 4 h after staining and treatment 
with rapamycin, MitoBlue also partly colocalized with the mRFP-GFP-LC3 autophagic marker, both with GFP+/
mRFP+ vesicles (Fig. 3B, empty arrow, additional examples are given under Fig. S2) and GFP−/mRFP+ vesicles 
(Fig. 3B, filled arrow), showing its travel through the whole mitophagic process. Importantly, MitoBlue signals 
are also found in GFP−/mRFP+ LC3 structures which are likely multivesicular bodies (Fig. 3B, circle), further 
suggesting that MitoBlue is transferred from mitochondria to lysosomes also via autophagic vesicles. On the other 
hand, the quick transfer to lysosomes in cells not treated with Rapamycin (Fig. 2), where mitophagy is a minor 
event, indicates that other transfer pathways should also be involved and that mitophagy represents a minor event 
in the transfer of Mitoblue from mitochondria to lysosomes.
In control galactose medium, MitoBlue showed dual localization in mitochondria and lysosomes as observed 
before (Fig. 3C, top panels), whereas in the presence of Antimycin A (AA), a mitochondrial complex III inhibitor 
that induces the formation of MDVs, MitoBlue showed a preferential accumulation in lysosomes (Fig. 3C, middle 
panels). Fusion between autophagosomes or late endosomes and lysosomes requires the lysosome acidification 
by lysosomal membrane V-ATPase. In the presence of the V-ATPase inhibitor Bafilomycin A1 (BA), MitoBlue 
signals accumulated in cytoplasm without colocalizing with neither MTDR nor Lamp1b (Fig. 3C, arrowheads in 
lower panels), supporting the idea that MitoBlue is transferred to lysosomes by a biological process(es) accompa-
nied with membrane dynamics instead of free diffusion. In addition, incubation of Mitoblue-labelled cells with 
100 µM hydroxychloroquine that inhibits mitophagy also by inhibiting the lysosome acidification did not stop 
the migration of the dye from mitochondria to vesicles (Fig. S1). Thus, these results also suggest that MitoBlue 
dynamics are associated to different pathways of mitochondrial degradation or recycling46.
MitoBlue is transferred from mitochondria to lysosomes without any chemical modifica-
tion. It cannot be discarded that the migration of MitoBlue from mitochondria to lysosomes might be asso-
ciated to some chemical modification (perhaps oxidation). To clarify this question regarding the nature of the 
compound that is being targeted to the lysosomes, we incubated Vero cells with MitoBlue following the outlined 
protocol. After 9 h post-staining to ensure the transfer of MitoBlue to the lysosomes, cells were washed and har-
vested. Similarly treated cells were observed under the fluorescence microscope to assess the transference of 
the stain to the lysosomes (not shown). After metabolic extraction (see Methods), the pellet was analyzed by 
high-performance liquid chromatography (HPLC). The results in Fig. 4 show that the only difference between 
the material obtained from untreated cells (a) and that from MitoBlue-treated cells (b) is a single peak presenting 
exactly the same retention time than purified MitoBlue (c). These results are consistent with the chemical struc-
ture of MitoBlue being maintained through the whole process of mitochondrial staining and subsequent transfer 
to the lysosomes.
Studying the dynamics of mitochondrial recycling with MitoBlue. The above data suggest that 
MitoBlue could be used to monitor the fate of mitochondrial contents. Thus, we compared the rates of trans-
fer of MitoBlue to lysosomes between freshly prepared CEF cells, or CEF that were kept in culture for 10 days 
to induce culture-induced senescence. The presence of increased β-Galactosidase activity in the ten days-old 
cultured CEF cells clearly indicated their senescence status (Fig. 5A, SABG column). As can be seen in Fig. 5A, 
at 1.5 h post-MitoBlue treatment, freshly harvested CEF showed a significant overlap between MitoBlue and 
Mitotracker Red staining (Fig. 5A, top row). On the other hand, older CEFs displayed a completely remodeled 
MitoBlue pattern, equivalent to what is observed in the fresh culture after longer post-MitoBlue staining (Fig. 5A, 
bottom row), suggesting a higher mitochondria recycling rate.
MitoBlue is suitable for Two-photon microscopy. The ability of MitoBlue to act as a general marker 
for mitochondria is somewhat compromised by its relatively short excitation wavelength (λexc 329 nm). Thus, 
as a possible improvement for this dye, we decided to carry put a preliminary exploration of the performance 
of MitoBlue as a fluorophore in two-photon fluorescence excitation microscopy (TPM). TPM is based on the 
unique characteristics of the two-photon absorption process occurring in probes when excited at long excita-
tion wavelength (700 to 1000 nm). The technique can enable the visualization of intracellular organelles of liv-
ing specimens with advantages over conventional fluorescence microscopy such as increased light penetration 
A (AA) with or without 50 nM Bafilomycin A (BA) for 2 h. BA was added to cells 30 min prior to MitoBlue. 
Immunofluorescence staining was performed using anti-Tom20 antibody. Arrowheads indicate MitoBlue not 
co-localizing with Tom20 and Lamp1b.
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depth, lower auto-fluorescence levels, reduced phototoxicity and photobleaching, as well as the possibility of 
three-dimensional imaging of living tissues and longer observation times47,48.
To confirm the potential of MitoBlue for TPM, we tested its luminescent response in water, under two-photon 
excitation conditions using a 740 nm excitation wavelength (Fig. 6A left). As expected, the compound showed 
an emission spectrum maximum at c.a. 500 nm. The two photon absorption (TPA) cross-sections were deter-
mined using the Two Photon Excited Fluorescence (TPEF) method, assuming that the quantum efficiencies after 
two-photon excitation are the same as those after one-photon excitation49,50. TPA cross-sections were obtained 














where δ is the TPA cross-section, C and η are the concentration and refractive index of the sample solution, and 
F is the integrated area under the TPEF spectrum. MitoBlue shows TPA cross-sections δ values of 6.0 GM [1 GM 
(Goeppert–Mayer unit) = 10−50 cm4 s molecule–1 photon−1] at 740 nm. The two photonic nature of the observed 
phenomena was confirmed by the quadratic dependence of the emission on the laser power.
To test the practical applicability of MitoBlue for cell imaging, cultured N13 mouse microglia cells were 
incubated with 5 µM MitoBlue and 50 nM Mitotracker for 45 min under standard growth conditions. Cells were 
washed with fresh growth medium and examined directly by TPM, observing the characteristic blue emission 
of the compound that, as expected, colocalized with that of Mitotracker Red using the same 740 nm two-photon 
excitation (TPE) wavelength (Fig. 6C)51.
Discussion
MitoBlue is a synthetic bisbenzamidine derivative that stains mitochondria with high specificity through a still 
undetermined mechanism. The polarization of the mitochondrial membrane does not appear to be the main driv-
ing force directing MitoBlue to the mitochondria, indicating that other physicochemical effects or even specific 
interactions at the mitochondrial compartment are responsible such intracellular selectivity and staining. Thus, 
prolonged incubation with depolarizing agents seems to reduce the amount of MitoBlue reaching mitochondria, 
but short incubation times with these agents, that typically block other dyes, do not show any appreciable effect 
on the localization of MitoBlue. Although MitoBlue has a delocalized positive charge typical of mitochondrial 
dyes, MitoBlue is retained after fixation and, more importantly, transferred through membrane traffic processes 
to lysosomes through different pathways, a characteristic not shared with other available mitochondrial stains. 
Thus, these data suggest that there should be some interaction between MitoBlue and specific mitochondrial 
components that retains this stain in the mitochondria. We have previously demonstrated the ability of MitoBlue 
to specifically bind to DNA in vitro, so our initial hypothesis was that mitochondrial DNA might anchor our stain 
to the compartment. However, we show in this manuscript that there is no association between MitoBlue and 
mitochondrial DNA in living cells, therefore ruling out that possibility (Fig. 1).
We found that MitoBlue localizes with PDH and not with Tom20, which strongly suggests its association 
with the inner mitochondrial membrane (IMM). Cardiolipin (CL) is the most characteristic of the components 
of the IMM and amounts to up to 20% of its total lipid composition. Its large head group and its cone-shaped 
structure are unique between membrane lipids, and positively charged guanidinium and amidinium groups such 
as those present in MitoBlue are known to strongly interact with anionic species, including carboxylates and 
phosphates52,53, thus providing a strong supramolecular rationale for the interaction between MitoBlue and CL. 
Figure 4. MitoBlue structure is preserved during its transfer to lysosomes. (a) HPLC trace of metabolic 
extraction of untreated Vero cells (b) cells incubated with MitoBlue for 9 h, (c) stock solution of MitoBlue as 
reference.
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Furthermore, cationic aminoglycosides structurally resembling MitoBlue, such as 3,6-dinonyl neamine, have 
been shown to bind cardiolipin in cells54; CL is also present in the membranes of bacteria and mycoplasms, and 
both organisms are also targeted by MitoBlue (unpublished results). Altogether, these observations pont to CL as 
a likely responsible for the selective capture of MitoBlue in the IMM.
After reaching and staining mitochondria, MitoBlue is gradually transported out of this organelle, ending up 
in lysosomes. Such migration is not due to a chemical modification that might alter the affinity of the stain for 
the mitochondria (Fig. 5). There are currently four known pathways that enable mitochondrial quality control45. 
Two of them are specifically dedicated to degrade mitochondrial proteins: specific proteases in the mitochon-
drial matrix and intermembrane space degrade damaged proteins55, while some mitochondrial proteins at the 
outer membrane are degraded at the proteasome following ubiquitination56. On the other hand, dysfunctional 
mitochondria can be removed by their targeting to autophagosomes, through a mechanism called mitophagy, 
for whole organelle elimination49,57. Dysfunctional mitochondrial components can finally be incorporated into 
MDVs, vesicles that are ultimately targeted to lysosomes for recycling; this pathway not only takes care of protein 
recycling, but also processes membrane lipids and possibly other materials58,59. The characterization of these path-
ways relies on the use of tagged proteins or specific antibodies that target just a few of the more than 1000 proteins 
that are present in the mitochondria. More importantly, the latter two pathways need membrane dynamics and 
engage other membrane compartments.
In our study, we have explored the evolution of MitoBlue in both LC3-positive and negative structures 
(Fig. 3B), and showed that MitoBlue is incorporated into both mitophagic and MDVs pathways. Taking account 
of the low frequency of MDVs and mitophagy in untreated cells, direct contact is another possible mechanism 
for MitoBlue transfer from mitochondria to lysosomes49,60. These two organelles are highly dynamic, and form 
contact sites with other membrane compartments. In recent years, direct contact between mitochondria and lyso-
somes (multivesicular body as well) have been reported, including “kiss and run” events, where ions and lipids are 
transferred61. Some of such contacts could be mediating recycling processes by direct material transfer that might 
not be detected unless they include typically monitored mitochondrial proteins. Membrane contact sites can be 
evaluated with TEM or fluorescence microscope measuring the distance between membranes, or calculating the 
co-localization coefficient such as Mander’s and Pearson’s. Functional evaluation however, relies on probing mate-
rials that can be transferred between organelles and followed either by imaging analysis using florescence probes 
Figure 5. MitoBlue labels the steps in the mitochondrial life cycle, from functional mitochondria to the 
final lysosomal degradation. (A) Turnover of MitoBlue with culture age. Freshly harvested (fresh) and aged 
primary cultures of CEF cells (old) were stained with 5 µM MitoBlue, incubated for 3 h and then co-stained 
with Mitotracker Red. Identical samples were stained with X-Gal (SABG). Scale bars: 100 μm for brightfield 
images and 10 μm for the fluorescent pictures. (B) Schematic model to explain the behavior of MitoBlue in 
cells. a) MitoBlue firstly targets mitochondria. No lysosomal staining is observed; b) MitoBlue travels from 
mitochondria to lysosomes by MDVs, mitophagy and/or direct contact; c) MitoBlue dominantly labels 
lysosomes.
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or biochemical analysis, such as pulse-chase using radio isotopes. Between both methods, imaging analysis has 
the advantage of ensuring the direct localization of the probe. Because most probes used in these assays target 
organelles that are either the origin or the destination, they are not useful to directly analyze the transfer process. 
For example, calcium ions are transferred between endoplasmic reticulum and mitochondria. Since mitochon-
drial calcium uniporter possesses low affinity to calcium ions, membrane contact sites are required to generate a 
hot spot where calcium ions are concentrated high enough to be uptaken by mitochondria62,63.
In contrast, MitoBlue firstly targets mitochondria, then travels to lysosomes in various cell types and at dif-
ferent vital status. As the first target is not dependent on the mitochondrial status, MitoBlue is able to trace the 
dynamic processes. Transfer of MitoBlue from mitochondria to lysosomes is accelerated under incubation with 
hydrogen peroxide and in aged cells, where mitochondrial quality control may be activated. Therefore, MitoBlue 
can be used to easily monitor the changes in mitochondrial quality control mechanisms in different cells and 
cellular conditions. MitoBlue staining pattern is unique among mitochondrial stains and recombinant fluores-
cent probes, allowing to monitor in a non-invasive dynamic fashion the mitochondrial recycling mechanism in 
a variety of situations in living cells. MitoBlue represents a unique tool for the study of these processes that will 
allow the detailed characterization of communication between mitochondria and lysosomes.
Materials and Methods
Chemicals and antibodies. MitoBlue was synthesized as reported previously reported64. DMSO, carbonyl 
cyanide 3-chlorophenylhydrazone, antimycin A, bafilomycin A were purchased from Sigma. Mitotracker Red, 
Mitotracker Deep Red, and tetramethylrhodamine ethyl ester were purchased form Thermo Fisher. Rabbit poly-
colonal anti-Tom 20 antibody (# Sc-11415) and mouse monoclonal anti-Lamp1b antibody (# Sc-17768) were 
from Santa Cruz Biotecnology Inc., mouse monoclonal PDH antibody was from Abcam (# ab110333) and mouse 
monoclonal anti-DNA antibody was from Progen Biotechnik (# 6104). Anti-mouse and anti-rabbit conjugated 
secondary antibodies were all obtained from Sigma.
Standard labelling protocol for MitoBlue and other organulle-specific stains. Monolayers of the 
corresponding cell line were incubated with 5 μM MitoBlue in DMEM containing no additives, for 20–30 min 
Figure 6. Availability of MitoBlue in TPE. (A) Fluorescence spectrum (λexc = 740 nm, solid line), and 
excitation spectrum (λem = 740 nm, dashed line) of MitoBlue under TPE conditions. (B) Fluorescence spectra 
recorded inside the cell of MitoBlue (∙) and Mitotracker Red (○), λexc = 740 nm TPE conditions. (C) N13 cells 
incubated with 5 µM MitoBlue and 50 nM Mitotracker Red, two-photon excitation microscopy images recorded 
at λexc = 740 nm, with the emission channel at 480 nm for MitoBlue and 600 nm for Mitotracker Red. The white 
bar corresponds to 10 μm.
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at 37 °C. The cells were then washed 3 times with pre-warmed DMEM and finally overlayed with fresh DMEM 
containing 10% FBS and incubated for the times indicated in each experiment.
cell cultures. Specific-pathogen-free (SPF) 9-day old embryonated eggs were generously donated by MSN. 
Primary cultures of chicken embryo fibroblasts (CEF) were prepared from the chicken 9-day old embryos as 
described65, and grown in monolayers in medium 199 supplemented with 10% (w/v) tryptose-phosphate broth 
and 5% (v/v) calf serum. The study protocol is exempt from the need for ethical approval under Spanish law 
(R.D. 53/2013, Law 32/2007). COS-7, Vero and HeLa cells obtained from ATCC and MCH64 cells obtained 
from Montreal Children’s Hospital were grown in monolayers in medium D-MEM supplemented with 10% fetal 
bovine serum. For oxidative stress-induced MDVs experiments, cells were pre-treated with 50 nM of bafilomycin 
A1 for 30 min, then MitoBlue was added to cells. Culture medium was replaced with galactose medium supple-
mented with or without 30 mM of antimycin A and 50 nM of bafilomycin A1. After 3 h incubation, cells were fixed 
and subjected to immunofluorescence staining.
Multiphoton microscopy. The two-photon absorption cross-section were determined on a Leica SP5 AOBS 
MP instrument according to standard procedures and within a laser power regime where the fluorescence was 
proportional to the square of the laser excitation power. In this way it was ensures that only two-photon absorp-
tion occurred.
Samples were analysed using an inverted Leica SP5 AOBS MP confocal microscope equipped with a MaiTai 
Ti:Sapphire HP laser (Spectra-Physics, INc.) tunable between 690 and 1040 nm. The imaging was performed by 
using a 63xPLAN APO oil immersion objective (NA 1.4). The emission and excitation spectra data were regis-
tered with the Leica LAS AF software.
For testing the practical applicability of MitoBlue in cellular settings. N13 cells were incubated with 5 µM 
MitoBlue for 45 min prior to imaging.4 Live cells were observed in the microscope under optimal conditions in 
8-well glass-bottomed slides at 37 C and 5% CO2. Using TP excitation at 740 nm the characteristic blue emission 
of the compound could easily be detected using minimal power (<1% of max laser power) detecting emissions 
from 500–500 nm. To evaluate the localization of the dye, cells were co-stained with 2 µM of the mitochondrial 
marker Mitotracker Red CMX-ROS (Thermofisher). The ability of this marker to work under TPE conditions 
allowed the simultaneous visualization of both dyes.5 Fig. 2 shows TP microscopy images of N13 cells incu-
bated with 5 µM MitoBlue and 500 nM Mitotracker red with TP excitation at 740 nm and emissions detected 
at 500–500 nm and 565–605 nm, respectively. Transmitted brightfield images were captured separately using a 
405 nm laser. The emission spectra of both dyes recorded inside the cell, using 740 nm of excitation wavelength 
is also shown.
As we can observed, MitoBlue is co-localized with the mitochondrial marker, and can be easily visualized 
under TPM.
Transfections and IF microscopy. Plasmid ptfLC3 was a gift from Tamotsu Yoshimori (Obtained from 
Addgene, plasmid # 21074)66. Transfections of cell monolayers were done with the Lipofectamine Plus reagent 
(Invitrogen), according to the manufacturer’s instructions. Transfected cells were incubated at 37 °C for 18 to 
24 h, unless otherwise stated. For immunofluorescence studies, the cells were permeabilized by incubation with 
0.1% Triton X-100/PBS for 10 min at room temperature followed by incubation with 5% BSA/PBS for 10 min. The 
primary antibodies indicated for any particular experiment were added to cell monolayers in 5% FBS/PBS and 
incubated for 2 h at rt. After washing the monolayers three times with 5% FBS/PBS, cells were incubated for 1 h 
with secondary antibodies. Images were alternatively obtained with an Olympus DP-71 digital camera mounted 
on an Olympus BX51 fluorescence microscope, or with an Olympus IX70 equipped with a TillPhotonics camera. 
Confocal images were acquired either with an Olympus FV1000 confocal microscope or with an Andor Dragonfly 
spinning disk confocal system mounted on a Nikon TiE microscope equipped with a Zyla 4.2 PLUS camera 
(Andor). Colocalization was quantified as Pearson’s coefficient using JACoP, ImageJ plugin67.
Metabolic extraction of MitoBlue from stained cells. In order to confirm the stability and integrity of 
MitoBlue inside the cell, we incubated MitoBlue 20 µM for 45 min in a cell culture dish; the supernatant was dis-
carded and cells were rinsed with PBS and kept for 9 h in DMEM with FBS. The supernatant was discarded once 
more, the cells were rinsed with PBS and finally removed and lysated68–70.
Senescence-associated β galactosidase staining. Cultured cells were washed 3 times with PBS, fixed 
with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 in PBS and then overlayed with staining solu-
tion (1 mg/mL 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside, citric acid/sodium phosphate buffer pH 6.0, 
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 150 mM NaCl, and 2 mM MgCl2. After 2 h at 37 °C 
the staining solution was removed, the cells washed twice with PBS and mounted for microscopy.
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